Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COLD vs OLD Botox for Glabellar Lines
NCT05083286Phase 1Unknown
- Sponsor
- Clinical Testing of Beverly Hills
- Start
- Oct 2021
- Primary completion
- Aug 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of botulinum toxin type A in glabellar lines (2 arms), sponsored by Clinical Testing of Beverly Hills. Primary endpoint: Response Duration at 180 days. Status: unknown.
02
Drugs
botulinum toxin type A
03
Conditions
glabellar lines
Beyond the preview
Go deeper on NCT05083286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05083286.